Figure 6: Improved Post-Ischemic Recovery in Type 2 Diabetic Rats Following in Vivo HIF Hydroxylase Inhibition

Cardiac function (rate-pressure product) in control, type 2 diabetic and in vivo DMOG-treated type 2 diabetic rats, at normal flow, during ischemia, and following reperfusion (n = 5 per group). *p < 0.05 versus control, $p < 0.05 versus diabetic.